1 Day OBIO -0.19% DJIA 0.30% Russell 2K -0.61% Health Care/Life Sciences -1.75% ...

Last year, Google Maps on Android was revamped so that the main map view displayed information using sheets, and the entire app is now getting this visual redesign. Instead of place listings being ...

In this edition we focus on how investors can use Industry Specific data to run deep sector analysis in both discretionary and systematic ways. We also look at how supply chain data can help with ...

We developed the “Tumor-in-a-Tube” platform, using 4D light-sheet microscopy to explore the spatiotemporal dynamics of FNDs with 3D tumor spheroids. By monitoring the real-time NP sedimentation, ...

NA-831 is under clinical development by Biomed Industries and currently in Phase II ... GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis ...

PERRYVILLE — Perryville High School seniors presented their capstone research projects as part of the Project Lead the Way biomedical science program at PVHS on Wednesday evening in the school ...

During the interview, Williams said she was not happy with being forced to take medication — 7 pills daily — without being told why. “Where I am, okay, you have to get keys to unlock the ...

If you buy something via one of our links, we may earn a commission. The sheets are made with a tightly woven microfiber fabric that shoppers say feels "hotel-quality." The manufacturing process ...

These findings echo NHS data showing the percentage of women using the pill as their main form of contraception fell from 47% in 2012-13 to 27% in 2022-23. From our morning news briefing to a ...

Also on Monday, the company unveiled topline Phase II data for HRS9531, a subcutaneous dual agonist of the GLP-1 and GIP receptors—a mechanism of action that it shares with Eli Lilly’s tirzepatide. At ...

The long quest for powerful non-opioid drugs that treat pain without risk of addiction is nearing a milestone, in the form of a pill that could ... Still, based on the trial data and how ...